Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4765125 | Data in Brief | 2017 | 7 Pages |
Abstract
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40Â mg and 80Â mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Chemical Engineering (General)
Authors
Elise E. DeVito, Aryeh I. Herman, Noah S. Konkus, Huiping Zhang, Mehmet Sofuoglu,